Alberto Santiago-De
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Effect of Non-nucleoside Resistance-Associated Mutations on the Effectiveness of Long-Acting Cabotegravir + Rilpivirine Therapy: Insights From the Real-World RELATIVITY Cohort.
Journal: Open forum infectious diseases
Published: June 10, 2026
Determinants of long-acting cabotegravir plus rilpivirine discontinuation in real-world HIV care: insights from the relativity cohort.
Journal: AIDS (London, England)
Published: November 20, 2025
Long-acting cabotegravir and rilpivirine for the treatment of people with HIV: current landscape and challenges ahead.
Journal: The Journal of antimicrobial chemotherapy
Published: August 12, 2025
A prospective assessment of the efficacy and durability of long-acting cabotegravir and rilpivirine in individuals with HIV in Spain (RELATIVITY study).
Journal: The Journal of antimicrobial chemotherapy
Published: July 17, 2025
Genotyping not required for sustained effectiveness of long-acting cabotegravir plus rilpivirine: evidence from the RELATIVITY cohort.
Journal: AIDS (London, England)
Published: July 02, 2025
Genotyping not required for sustained effectiveness of long-acting cabotegravir plus rilpivirine: evidence from the RELATIVITY cohort.
Journal: AIDS (London, England)
Published: July 02, 2025
Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults With HIV (INSTINCT/GESIDA10918 Study).
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 24, 2025
Multicentre controlled open randomised clinical trial to assess efficacy and safety of an anti-tuberculosis drug combination based on optimised-dose rifampicin, optimised-dose moxifloxacin and optimised-dose linezolid for TB: the RML-TB trial protocol.
Journal: BMJ open respiratory research
Published: April 03, 2024
Qualitative evaluation of survey questions to assess treatment preference for daily oral or long‑acting injectable antiretroviral therapy among people living with HIV.
Journal: PloS one
Published: January 05, 2024
HTLV infection in persons with sexually transmitted diseases in Spain.
Journal: Frontiers in immunology
Published: August 15, 2023
Dolutegravir Plus 3TC in Virologically Suppressed PLWHIV: Immunological Outcomes in a Multicenter Retrospective Cohort in Spain during the COVID-19 Pandemic.
Journal: Viruses
Published: December 28, 2022
Predictors of in-hospital mortality in HIV-infected patients with COVID-19.
Journal: QJM : monthly journal of the Association of Physicians
Published: August 13, 2022
Last Updated: 09/26/2026